Nu Skin S&E
This article was originally published in The Rose Sheet
Executive Summary
Personal care division sales increase 4% to $113.1 mil. in fourth quarter, boosted by introduction of new products in Japan and opening of the Malaysian market, direct-seller announces in 1Feb. 4 sales release. For the year, sales in the personal care division declined 4% to $423.7 mil. Consolidated sales for the fourth quarter were $232.6 mil., an increase of 4%, and net income fell 16% to $13.6 mil. For 2001, sales were flat at $885.6 mil, while net income plummeted 18.5% to $50.3 mil. largely due to weakening of the Japanese yen, Nu Skin said. Provo, Utah marketer expects Olympic sponsorship will positively impact business in 2002 (2"The Rose Sheet" Dec. 3, 2001, Marketing In Brief)...
You may also be interested in...
Marketing In Brief
Avon: Peony Soft Musk women's fragrance will debut in February via direct-sell distribution channel, company says. "Petally" fragrance invokes "fresh, playful feeling" with top notes of freesia, water hyacinth and marigold. Middle accords of sweet muguet, peony and white lily dry down to accords of sandalwood, amber and vanilla. Promotions will includes a two-piece gift-with-purchase on launch that will include 5 oz. Peony Soft Musk Shower Gel and color-changing bath puff. Packaged in a clear bottle with frosted pink cap, Peony Soft Musk will be available in 1.7 oz. eau de cologne spray and will retail for $14.50...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.